Page last updated on July 16, 2024
REGENEREX PHARMA, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-06-24 12:02:27 EDT.
Filings
10-K filed on 2024-06-24
REGENEREX PHARMA, INC. filed a 10-K at 2024-06-24 12:02:27 EDT
Accession Number: 0001472375-24-000045
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. CYBERSECURITY. The Company’s cyber risk management strategy has consisted of a focus on minimizing our attach surface and leveraging industry standard cyber threat prevention, detection, and remediation tools. The Company assesses cyber security risk as follows: - We have executed on this strategy with a cloud-first approach, awareness training, and deliberate use of well-established vendors for software and hardware solutions. - The Company’s IT manager is engaging an independent service with its expertise specifically in cybersecurity and risk mitigation to review our IT as a risk service consultant. To date, no cybersecurity threats have materially affected our business strategy, operations, or financial condition.
Company Information
| Name | REGENEREX PHARMA, INC. |
| CIK | 0001357878 |
| SIC Description | Pharmaceutical Preparations |
| Ticker | RGPX - OTC |
| Website | |
| Category | Non-accelerated filer Smaller reporting company Emerging growth company |
| Fiscal Year End | March 30 |